drugset / Trial / NCT04445311
Ivermectin in Treatment of COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
confirmed cases with COVID-19 will receive ivermectin as a therapeutic option as well as standard of care treatment and will be compared to those that will receive only standard of care ttt
Timeline
- Start
- 2020-05-31
- Primary completion
- 2020-07-30
- Completion
- 2020-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | — | — |